Concepedia

Panos Zanos

PZ

Statistics

Publications

55

Citations

4.3K

H-Index

31

Active since

2013

Affiliations

University of Maryland, Baltimore(Current)

VA Maryland Health Care System

National Institutes of Health

National Institute of Mental Health

University of Surrey

Panos Zanos is an author at University of Maryland, Baltimore specializing in neuropharmacology, medicine, and pharmacology.

ORCID

Publications per year

2013–2025

55

Publications

55

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Panos Zanos, Ruin Moaddel, Patrick J. Morris et al. · Nature · 2016 · 1.6K citations · Full text

, , +14

Antidepressant-relevant concentrations of the ketamine metabolite (2 <i>R</i> ,6 <i>R</i> )-hydroxynorketamine do not block NMDA receptor function

Eric W. Lumsden, Timothy A. Troppoli, Scott J. Myers et al. · Proceedings of the National Academy of Sciences · 2019 · 158 citations · Full text

, , +17

( <i>2R,6R</i> )-hydroxynorketamine exerts mGlu <sub>2</sub> receptor-dependent antidepressant actions

Panos Zanos, Jaclyn N. Highland, Brent W. Stewart et al. · Proceedings of the National Academy of Sciences · 2019 · 153 citations · Full text

, , +17

Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor

Polymnia Georgiou, Panos Zanos, Ta-Chung M. Mou et al. · Nature Neuroscience · 2022 · 135 citations · Full text

, , +10

The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Stress-Induced Reinstatement of Opioid-Seeking in Morphine-Abstinent Mice

Panos Zanos, Polymnia Georgiou, Sherie R. Wright et al. · Neuropsychopharmacology · 2013 · 133 citations

, , +14

1–5 of 55